Clinical trial
Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population
NCT04322461
Study timeline
Study start (actual)2022-05-01Date precision: day
Registry last updated2025-06-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Diseaseunresolved
Alzheimer Diseaseunresolved
Interventions
Betaquik MCT supplementDIETARY_SUPPLEMENT
Sponsors & collaborators
Université de Sherbrookelead sponsor
Société des Produits Nestlé (SPN)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04322461 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.